GE Healthcare tops the list of FDA-approved AI medical devices

The international healthcare company GE HealthCare has reached the top US Food and Drug Administration (FDA) list of artificial intelligence-enabled medical devices.

GE HealthCare is investing in artificial intelligence and machine learning (ML) to enhance its precision care offering, which integrates multiple technologies including advanced medical imaging, artificial intelligence and molecular diagnostics.

These solutions are used to tailor diagnosis, treatment, and ongoing monitoring and management to achieve optimal patient outcomes.

GE HealthCare also topped the list after the FDA updated it in 2022 and 2023.

The healthcare problems GE HealthCare is tackling with AI-powered technology include data overload, physician burnout and real-time operational efficiencies that enable healthcare professionals to deliver precision care.

GEHealthcare ‘pushes the boundaries of artificial intelligence’

Dr. Taha Kass-Hout, chief science and technology officer at GE HealthCare, said: “GE HealthCare is committed to pushing the boundaries of what is possible, using advanced technologies like artificial intelligence to help create the future of healthcare.

“GE HealthCare’s continued leadership in the authorization of AI-powered medical devices demonstrates our commitment to delivering breakthrough technology that transforms healthcare and improves patient outcomes.”

AI and ML-enabled medical devices are on the list of FDA-authorized devices, and the latest one includes 72 mentions of GE HealthCare, including solutions from recently acquired companies including BK Medical, Caption Health and MIM Software.